Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB06Other hematological agents
- Pharmacological subgroupB06A
- Chemical subgroupB06AC
- Chemical substanceB06AC05Lanadelumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 4 registrations
Netherlands
CBG-MEB · 4 registrations
- TAKHZYRO 150 mg oplossing voor injectie in voorgevulde spuitOplossing voor injectie · Takeda Pharmaceuticals International AG Ireland Branch
- TAKHZYRO 300 mg oplossing voor injectieOplossing voor injectie · Takeda Pharmaceuticals International AG Ireland Branch
- TAKHZYRO 300 mg oplossing voor injectie in voorgevulde penOplossing voor injectie · Takeda Pharmaceuticals International AG Ireland Branch
At a glance
- ATC code
- B06AC05
- ATC group
- Blood and blood-forming organs
- Registers
- 9
- Historical lists
- 1
- Registrations
- 26
- With their own page
- 22
- Companies
- 13
All medicines with Lanadelumab
Human medicines from every register that match Lanadelumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
26 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Takhzyro | United States | 300MG/2ML | solution | Marketed | Dyax Corp. |
| Takhzyro | United States | 150MG/1ML | Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Takhzyro | European Union | Authorised | Takeda Pharmaceuticals International AG Ireland Branch | ||
| Takhzyro 150 MG Solucion Inyectable en Jeringa Precargada | Spain | 150 mg | solución inyectable | Marketed | Takeda Pharmaceuticals International Ag Ireland Branch |
| Takhzyro 300 MG Solucion Inyectable en Jeringa Precargada | Spain | 300 mg | solución inyectable | Marketed | Takeda Pharmaceuticals International Ag Ireland Branch |
| TAKHZYRO 150 mg oplossing voor injectie in voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Takeda Pharmaceuticals International AG Ireland Branch | |
| TAKHZYRO 300 mg oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Takeda Pharmaceuticals International AG Ireland Branch | |
| TAKHZYRO 300 mg oplossing voor injectie in voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | Takeda Pharmaceuticals International AG Ireland Branch | |
| TAKHZYRO 300 mg oplossing voor injectie in voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Takeda Pharmaceuticals International AG Ireland Branch | |
| Takhzyro 300 MG Solucion Inyectable | Spain | 300 mg | solución inyectable | Authorised | Takeda Pharmaceuticals International Ag Ireland Branch |
| Takhzyro | Canada | 300 MG / 2 ML | Solution | Marketed | Takeda Canada INC |
| Takhzyro | Canada | 300 MG / 2 ML | Solution | Marketed | Takeda Canada INC |
| Takhzyro | Canada | 300 MG / 2 ML | Solution | Marketed | Takeda Canada INC |
| Takhzyro | Brazil | Authorised | Takeda Farmaceutica Brasil Ltda | ||
| Takhzyro | Serbia | 300mg | rastvor za injekciju u napunjenom injekcionom špricu | Authorised | Takeda DOO |
| Takhzyro | Canada | 150 MG / ML | Solution | Authorised | Takeda Canada INC |
| Takhzyro | Serbia | 150mg | rastvor za injekciju u napunjenom injekcionom špricu | Authorised | Takeda DOO |
| Takhzyro | Serbia | 300mg | rastvor za injekciju u napunjenom injekcionom penu | Authorised | Takeda DOO |
| Takhzyro | Serbia | 300mg | rastvor za injekciju u napunjenom injekcionom penu | Authorised | Takeda DOO |
| Takhzyro Solution for Injection in Pre-Filled Syringe 150MG/ML | Singapore | 150mg/mL | injection, solution | Authorised | Takeda Pharmaceuticals (Asia Pacific) Pte. LTD. |
| Takhzyro Solution for Injection in Pre-Filled Syringe 300MG/2ML | Singapore | 300mg/2mL | injection, solution | Authorised | Takeda Pharmaceuticals (Asia Pacific) Pte. LTD. |
| Takhzyro | Croatia | Marketed | |||
| Takhzyro | Saudi Arabia | Authorised | Catalent Indiana LLC formerly Cook Pharmica LLC | ||
| Takhzyro | Saudi Arabia | Authorised | Vetter Pharma | ||
| Takhzyro | Brazil | Cancelled | Takeda Pharma Ltda. |